PM3 USE OF PHARMACOGENETIC TESTING TO DETERMINE ADJUVANT HORMONAL THERAPY CHOICE IN EARLY STAGE BREAST CANCER PATIENTS- A VALUE OF INFORMATION ANALYSIS

May 1, 2009, 00:00
10.1016/S1098-3015(10)73082-5
https://www.valueinhealthjournal.com/article/S1098-3015(10)73082-5/fulltext
Title : PM3 USE OF PHARMACOGENETIC TESTING TO DETERMINE ADJUVANT HORMONAL THERAPY CHOICE IN EARLY STAGE BREAST CANCER PATIENTS- A VALUE OF INFORMATION ANALYSIS
Citation : https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)73082-5&doi=10.1016/S1098-3015(10)73082-5
First page :
Section Title :
Open access? : No
Section Order : 679
Categories :
Tags :
Regions :
ViH Article Tags :